Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin Retard for Postoperative Pain After Laparoscopic Abdominal Surgery
NCT07456761Not yet recruiting
- Sponsor
- South Egypt Cancer Institute
- Start
- Apr 2026
- Primary completion
- Nov 2026
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of pregabalin in postoperative pain (2 arms), sponsored by South Egypt Cancer Institute. Primary endpoint: Cumulative opioid consumption at 24 hours. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
pregabalin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07456761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07456761.